ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD57.414

D57.414

Billable

Sickle-cell thalassemia, unspecified, with dactylitis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D57.414 is a billable code used to indicate a diagnosis of sickle-cell thalassemia, unspecified, with dactylitis.

Key Diagnostic Point:

Sickle-cell thalassemia is a genetic blood disorder characterized by the presence of both sickle cell disease and thalassemia, leading to a complex form of hemolytic anemia. Patients with this condition experience abnormal hemoglobin production, resulting in sickle-shaped red blood cells that can cause vaso-occlusive crises, pain, and various complications. Dactylitis, or hand-foot syndrome, is a common manifestation in children with sickle cell disease, presenting as painful swelling of the fingers and toes due to vaso-occlusion in the small blood vessels. This condition can lead to significant morbidity, requiring careful management and monitoring. The unspecified nature of this code indicates that the specific type of thalassemia (alpha or beta) is not documented, which can complicate treatment and management strategies. Genetic factors play a crucial role in the inheritance of both sickle cell disease and thalassemia, necessitating thorough family history assessments and genetic counseling for affected individuals.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between types of thalassemia and sickle cell disease.
  • Understanding the implications of dactylitis in clinical management.
  • Need for precise documentation of symptoms and genetic background.
  • Potential for co-morbid conditions that may complicate coding.

Audit Risk Factors

  • Inadequate documentation of genetic testing results.
  • Failure to specify the type of thalassemia.
  • Misclassification of dactylitis severity.
  • Lack of detailed clinical notes on patient history.

Specialty Focus

Medical Specialties

Hematology

Documentation Requirements

Detailed lab results, genetic testing, and clinical notes on symptoms.

Common Clinical Scenarios

Management of pain crises, blood transfusions, and monitoring for complications.

Billing Considerations

Understanding the interplay between sickle cell disease and thalassemia for treatment planning.

Pediatrics

Documentation Requirements

Growth and development assessments, family history, and vaccination status.

Common Clinical Scenarios

Management of dactylitis and routine health maintenance in children.

Billing Considerations

Monitoring for developmental delays and psychosocial impacts of chronic illness.

Coding Guidelines

Inclusion Criteria

Use D57.414 When
  • Follow the ICD
  • CM guidelines for coding hemolytic anemias and ensure accurate documentation of the patient's clinical status
  • Include specific details about dactylitis and any related complications

Exclusion Criteria

Do NOT use D57.414 When
  • Exclude codes that do not specify the type of thalassemia or sickle cell disease

Related ICD-10 Codes

Related CPT Codes

36415CPT Code

Collection of venous blood by venipuncture

Clinical Scenario

Used for routine blood tests to monitor hemoglobin levels.

Documentation Requirements

Document the reason for blood draw and any relevant patient history.

Specialty Considerations

Hematologists may require additional tests for hemoglobin electrophoresis.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of hemolytic anemias, including sickle-cell thalassemia. This specificity aids in better tracking of patient outcomes and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of hemolytic anemias, including sickle-cell thalassemia. This specificity aids in better tracking of patient outcomes and resource allocation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of hemolytic anemias, including sickle-cell thalassemia. This specificity aids in better tracking of patient outcomes and resource allocation.

Resources

Clinical References

  • •
    Sickle Cell Disease Association of America

Coding & Billing References

  • •
    Sickle Cell Disease Association of America

Frequently Asked Questions

What is the significance of dactylitis in sickle-cell thalassemia?

Dactylitis is a common early manifestation of sickle cell disease in children, indicating vaso-occlusive events. It is important for diagnosis and management, as it can lead to further complications if not addressed.